HIF1A and breast carcinoma: Indeed, in breast cancer cell line (MDA-MB-231), the inhibition of HIF-1α expression using cardamonin repressed the mechanistic target of rapamycin (MTOR) pathway causing increased OXPHOS activity and enhanced ROS, which finally led to apoptosis [71].